Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2014-08-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study The investigators propose that the sperm quality may has influence in the embryo division.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?
NCT02214537
INTEnsity of ovariaN Stimulation and Embryo Quality
NCT04983173
Impact of Nuclear Human Sperm Quality on Embryo Development
NCT03320590
Comparison of in Vitro Fertilization Rates of Oocytes and Embryo Development Using Two Techniques of Semen Processing
NCT03186170
Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation.
NCT04003337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Good prognosis
Sperm samples \>15mill/ml \>30% progresive sperms
No interventions assigned to this group
bad prognosis
Sperm samples \<5mill/ml \<5% progresive sperms
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sperm samples with less than 5 mill/ml of sperms, less than 10% of mobile sperms
Exclusion Criteria
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IVI Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
david agudo, PhD
Role: PRINCIPAL_INVESTIGATOR
lab coordinator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI MAdrid
Madrid, , Spain
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
semen-esd
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.